Yiran Si

632 total citations
24 papers, 347 citations indexed

About

Yiran Si is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yiran Si has authored 24 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Yiran Si's work include Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related gene regulation (3 papers). Yiran Si is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related gene regulation (3 papers). Yiran Si collaborates with scholars based in China, United States and New Zealand. Yiran Si's co-authors include Dongzhi Hu, Jian Yue, Peng Yuan, Jiayi Han, Kegan Zhu, Dalu Kong, Haiyang Zhang, Ming Bai, Xue Wang and Haiou Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yiran Si

22 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiran Si China 9 227 194 81 45 45 24 347
Marta De Menna Switzerland 10 246 1.1× 155 0.8× 85 1.0× 64 1.4× 18 0.4× 15 379
Nils Degrauwe Switzerland 5 342 1.5× 198 1.0× 59 0.7× 24 0.5× 13 0.3× 7 431
Gentian Musa Italy 7 257 1.1× 187 1.0× 61 0.8× 31 0.7× 16 0.4× 10 348
Berthold Gierke Germany 8 148 0.7× 72 0.4× 105 1.3× 32 0.7× 42 0.9× 12 277
Ellen C. de Heer Netherlands 7 168 0.7× 139 0.7× 111 1.4× 70 1.6× 41 0.9× 8 345
Yue‐Ju Li Taiwan 9 243 1.1× 174 0.9× 71 0.9× 21 0.5× 11 0.2× 11 326
Jihong Zhou China 11 259 1.1× 178 0.9× 42 0.5× 29 0.6× 15 0.3× 21 340
Ziqin Liu China 9 192 0.8× 89 0.5× 46 0.6× 24 0.5× 13 0.3× 26 275
Yu Lv China 9 236 1.0× 167 0.9× 29 0.4× 26 0.6× 21 0.5× 16 306
Iskander Aurrekoetxea-Rodríguez Spain 6 136 0.6× 84 0.4× 114 1.4× 21 0.5× 25 0.6× 7 277

Countries citing papers authored by Yiran Si

Since Specialization
Citations

This map shows the geographic impact of Yiran Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiran Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiran Si more than expected).

Fields of papers citing papers by Yiran Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiran Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiran Si. The network helps show where Yiran Si may publish in the future.

Co-authorship network of co-authors of Yiran Si

This figure shows the co-authorship network connecting the top 25 collaborators of Yiran Si. A scholar is included among the top collaborators of Yiran Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiran Si. Yiran Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Si, Yiran, Deliang Li, Wenjing Ren, et al.. (2025). Long-Term Regulation of IL-17 Expression in Pacific Oyster Hemocytes by mGluR5 Through the Phosphoinositide Pathway. Cells. 14(6). 438–438. 1 indexed citations
2.
Li, Deliang, Wenjing Ren, Xueshu Zhang, et al.. (2025). Mixed algal diets enhance glutamate metabolism to promote growth and development in Pacific oyster (Magallana gigas) larvae. Aquaculture International. 33(6).
3.
Zhang, Xueshu, Yiran Si, Deliang Li, et al.. (2024). Glutamate induces larval settlement of the pacific oyster Crassostrea gigas. Aquaculture and Fisheries. 11(1). 40–44. 2 indexed citations
4.
Zhang, Xueshu, et al.. (2024). Involvement of metabotropic glutamate receptors in regulation of immune response in the Pacific oyster Crassostrea gigas. Fish & Shellfish Immunology. 151. 109709–109709. 3 indexed citations
5.
Wang, Xue, Feng Du, Jian Yue, et al.. (2023). Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer. Cancer Biology and Medicine. 20(2). 155–168. 7 indexed citations
6.
Zhang, Xueshu, et al.. (2023). Unveiling the functional diversity of ionotropic glutamate receptors in the Pacific oyster (Crassostrea gigas) by systematic studies. Frontiers in Physiology. 14. 1280553–1280553. 2 indexed citations
7.
Li, Xiaoqing, et al.. (2023). Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple‐negative breast cancer. SHILAP Revista de lepidopterología. 2(5). 376–390. 2 indexed citations
8.
Du, Feng, Songlin Gao, Yiran Si, et al.. (2022). Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer. Breast Cancer Research and Treatment. 194(2). 221–230. 5 indexed citations
9.
Wang, Xue, Feng Du, Jian Yue, et al.. (2022). Abstract 5084: KMT2D and PIK3CA mutation as potential factors to predict adjuvant chemotherapy efficacy in surgical triple negative breast cancer. Cancer Research. 82(12_Supplement). 5084–5084.
10.
Zheng, Fangchao, Feng Du, Haili Qian, et al.. (2021). Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer. Biomarker Research. 9(1). 28–28. 23 indexed citations
11.
Si, Yiran, Jian Yue, Zhaoyang Liu, et al.. (2021). Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer. International Journal of Nanomedicine. Volume 16. 1913–1926. 41 indexed citations
12.
Yue, Jian, et al.. (2021). The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer. Frontiers in Oncology. 11. 759595–759595. 6 indexed citations
13.
Zheng, Fangchao, Feng Du, Jiuda Zhao, et al.. (2021). The emerging role of RNA N6-methyladenosine methylation in breast cancer. Biomarker Research. 9(1). 39–39. 29 indexed citations
14.
Si, Yiran, Jian Yue, Tingting Sun, et al.. (2021). Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer. Cancer Biology and Medicine. 18(3). 849–859. 28 indexed citations
15.
16.
Du, Feng, Songlin Gao, Yiran Si, et al.. (2021). The intra-tumor heterogeneity of ER and HER2 expression in patients with ER-positive and HER2-positive breast cancer.. Journal of Clinical Oncology. 39(15_suppl). e12550–e12550. 2 indexed citations
17.
Si, Yiran, Peng Yuan, Xue Wang, et al.. (2020). Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life. Annals of Surgical Oncology. 27(4). 1025–1033. 14 indexed citations
18.
Ning, Tao, Shuang Li, Yanjun Qu, et al.. (2017). miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer. Oncology Reports. 38(1). 175–182. 25 indexed citations
19.
Si, Yiran, Haiyang Zhang, Tao Ning, et al.. (2017). miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma. Cellular Physiology and Biochemistry. 42(4). 1670–1683. 33 indexed citations
20.
Wang, Junyi, Haiou Yang, Yiran Si, et al.. (2017). Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1. Cellular Physiology and Biochemistry. 43(4). 1325–1336. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta De Menna Breakdown of academic impact, for papers by Nils Degrauwe Breakdown of academic impact, for papers by Gentian Musa Breakdown of academic impact, for papers by Berthold Gierke Breakdown of academic impact, for papers by Ellen C. de Heer Breakdown of academic impact, for papers by Yue‐Ju Li Breakdown of academic impact, for papers by Jihong Zhou Breakdown of academic impact, for papers by Ziqin Liu Breakdown of academic impact, for papers by Yu Lv Breakdown of academic impact, for papers by Iskander Aurrekoetxea-Rodríguez
Rankless by CCL
2026